MedTrace Logo

The Effective Effect-Site Propofol Concentration for Induction and Intubation for Schnider Model in Parturients

NCT02554175 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2015-09-18

No results posted yet for this study

Summary

The aim of this study was to determine the target propofol concentration needed to provide adequate hypnosis for induction and tracheal intubation for Schnider model using total body weight (TBW) in parturients. In addition, investigators wanted to define the hemodynamic adverse effects associated with these propofol target concentrations.

Conditions

  • C.Delivery; Surgery (Previous), Gynecological

Interventions

DRUG

Propofol

Propofol was administered to achieve target propofol Ce

Sponsors & Collaborators

  • Fudan University

    lead OTHER

Principal Investigators

  • Shaoqiang Huang · Department of Anesthesiology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2017-08-31
Completion
2017-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02554175 on ClinicalTrials.gov